I was reading over this thread with great interest.
I am interested in epigenetic gene silencing through hypermethylation of a specific gene promoter.
Epigenetic gene silencing has long been implicated in cancer and its role in other diseases is becoming much more recognised in recent years.
Abherant promoter gene silencing occurs when a methyltransferase such as Mecp2 attachs methyl groups to cgp islands on a particular gene promoter. This can happen locally - such as at the site of a tumour formation - or over the whole body as is implicated in essential hypertension.
Here is some basic reading:
http://www.dreammanifesto.com/epigeneti ... genes.html
http://clincancerres.aacrjournals.org/c ... /1219.full
and in diabetes type II:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184044
Do a search on aberrant methylation in google and there are thousands of topics. All sorts of diseases are involved.
BUT the article that caught my attention is this one:
http://www.citeulike.org/user/guhjy/article/6201812
quote:
Quote:
We propose that epigenetic side-effects of pharmaceuticals may be involved in the etiology of heart disease, cancer, neurological and cognitive disorders, obesity, diabetes, infertility, and sexual dysfunction. It is suggested that a systems biology approach employing microarray analyses of gene expression and methylation patterns can lead to a better understanding of long-term side-effects of drugs, and that in the future, epigenetic assays should be incorporated into the safety assessment of all pharmaceutical drugs. This new approach to pharmacology has been termed
My interest in this area started when my doctor who diagnosed me with a condition where an epigenetic change has occured to a gene asked me whether I had taken any medications at the time that I began experiencing symptoms.
They had been able to demonstrate that other medications had hypermethylated this particular gene but I wont mention which medications they were because the work was never published in a medical journal.
However, later I remembed that I began experiencing symptoms around hte time that I began taking finestaride.
The bad news is that is not possible to normally obtain a test to assess the methylation status of particular genes. I was able to in my case and the methylation on the specific gene promoter was 100%! The gene was totally non functioning.
The good news is that there are already a number of medications that have been shown - through various mechanisms - to inhibit the transfer of methyl groups to replicated DNA - demethylating agents:
http://en.wikipedia.org/wiki/Demethylating_agent
http://en.wikipedia.org/wiki/Azacitidine
and some natural demethylators:
http://www.cancercompass.com/message-bo ... mid=303055